Icon

YEZTUGO (NDA220018)- (463.5MG/1.5ML(309MG/ML))

LENACAPAVIR GILEAD SCIENCES INC
463.5MG/1.5ML(309MG/ML)
No No
Expired Expired
None None
None No
YEZTUGO is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition. Individuals must have a negative HIV-1 test prior to initiating YEZTUGO
0 0 0
Total Other Developers None
Drugs with Suitability No
463.5MG/1.5ML(309MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.